Patient-Centered Approach in IBS-C Management.

作者信息

Kongara Kavita

机构信息

Motility Clinical Chair, United Digestive Georgia Physician Executive Committee Member, United Digestive Physician, Atlanta Gastroenterology Associates Atlanta, Georgia.

出版信息

Gastroenterol Hepatol (N Y). 2025 Jun;21(6):362-373.

DOI:

PMID:40896757

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397800/

Abstract

摘要

相似文献

[1]

Patient-Centered Approach in IBS-C Management.

Gastroenterol Hepatol (N Y). 2025-6

[2]

Irritable Bowel Syndrome

2025-1

[3]

A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.

Am J Gastroenterol. 2024-9-1

[4]

Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome.

Aliment Pharmacol Ther. 2015-6

[5]

Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome.

Am J Transl Res. 2025-5-15

[6]

Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome.

Sci Rep. 2025-7-1

[7]

A Patient-Centered Approach to Managing IBS-C and CIC.

J Fam Pract. 2023-7

[8]

Exploring Dietitians' Perspectives Toward Current Practices and Services in Relation to Irritable Bowel Syndrome Management in Clinical Settings Across the United Kingdom: A Qualitative Study.

J Acad Nutr Diet. 2025-3

[9]

Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.

Nutr Rev. 2025-1-25

[10]

Diagnosis and management of IBS.

Nat Rev Gastroenterol Hepatol. 2010-10

本文引用的文献

[1]

Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation and Bloating: Evaluation Using Trisymptom Composite Endpoints.

Gastroenterol Hepatol (N Y). 2024-12

[2]

Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.

Gastroenterol Hepatol (N Y). 2024-12

[3]

Managing IBS-C: Focus on Symptom Control.

Gastroenterol Hepatol (N Y). 2024-4

[4]

Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.

Dig Dis Sci. 2024-5

[5]

Mechanism of Action Considerations in the Management of IBS-C.

Gastroenterol Hepatol (N Y). 2023-12

[6]

Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.

Am J Gastroenterol. 2024-5-1

[7]

Differential Diagnosis of Chronic Diarrhea: An Algorithm to Distinguish Irritable Bowel Syndrome With Diarrhea From Other Organic Gastrointestinal Diseases, With Special Focus on Exocrine Pancreatic Insufficiency.

J Clin Gastroenterol. 2023-8-1

[8]

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.

Nutrients. 2023-3-28

[9]

Approach to Disorders of Gut-Brain Interaction.

Mayo Clin Proc. 2023-3

[10]

The neurobiology of irritable bowel syndrome.

Mol Psychiatry. 2023-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Patient-Centered Approach in IBS-C Management.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献